sectors, and community groups, could prioritize actions based on an understanding of the gap between the total population's current and potential HALE. Thus, analogous to the patient described above, these stakeholders could prioritize tobacco control (e.g., increasing tobacco taxes or promoting quit lines to the highest-risk groups), interventions to stimulate greater physical activity (e.g., safer streets or forming walking groups), or interventions to enhance adult immunizations (e.g., reminders or incentives) with an understanding of the potential short-and long-term gains in HALE.
In many cases, the priorities for individuals and populations will be similar, since healthrelated behaviors are powerful determinants of longevity and well-being. But the greatest determinants of health in population terms may be quite different from those commonly addressed by clinicians. Social and environmental factors, including safe, affordable housing; high school graduation; early childhood development; employment; income; and access to healthy foods account for about half of the differences in health among populations.
Economic evaluations merging cost and productivity data with HALE estimates would help guide health investments to get the most "bang for society's buck"-and may also lead health care systems and hospitals' community benefit programs to look beyond their walls to affect the social determinants of health. Moreover, a simple, understandable measure such as HALE facilitates comparisons across geographic regions as well as among ethnic and socioeconomic groups. Such comparisons can motivate change by enhancing understanding of health disparities and the potential of interventions to mitigate them.
A research agenda to support consistent HALE measurement and implementation could undertake two linked aims. First, methodologic difficulties in computing HALE-particularly techniques for collecting and standardizing quality-of-life data-must be addressed. Existing patient-reported survey tools used to measure quality of life have generally been deployed in research settings or for community health assessments. Further refinement to improve internal consistency and usability would facilitate more general clinical use. Meanwhile, an acceptably robust life expectancy prediction model needs to be deployed. Second, almost as important as measurement is the framing of HALE results, particularly to individuals. Many intrinsically understand a complex concept like gross domestic product, although few could describe how it is calculated. Communicating HALE should strive for a similarly intuitive understanding-while drawing upon tenets of behavioral economics to maximally motivate change. For example, the concept of "loss aversion" suggests that presenting HALE data as "healthy life-years lost" could motivate greater behavior change than simply presenting an adjusted life expectancy or a summary health score. Ultimately, multiple approaches should be tested empirically to gather data on individuals' responsiveness and downstream effects on health outcomes.
Policy reforms could help support a research and implementation strategy in three principal ways. First, the National Center for Health Statistics of the Centers for Disease Control and Prevention should facilitate standardization of quality-of-life measurement, as described above, and facilitate its incorporation into the Behavioral Risk Factor Surveillance System and other population health surveys. Second, the Department of Health and Human Services should undertake an effort to collapse the three current measures it uses to track "healthy life expectancy" in Healthy People 2020 into a single HALE measure that includes self-reported quality of life. Third, the U.S. Preventive Services Task Force and the Community Preventive Services Task Force should collaborate to endorse consensus methods for calculating interventions' benefits in terms of HALE.
